Harrell Investment Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Harrell Investment Partners's EW Position: Q2 2025 in Review
Harrell Investment Partners sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 17,296 shares — an estimated $1.25M sold.
Harrell Investment Partners first reported a position in EW in Q3 2020 and held it in 19 quarters. The position peaked at $3.16M in Q4 2021. 1,261 funds tracked by Wall St. Rank hold EW as of Q2 2025.
- Harrell Investment Partners reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
- Harrell Investment Partners sold 17,296 Edwards Lifesciences shares in Q2 2025, an estimated $1.25M.
- Harrell Investment Partners first reported a position in Edwards Lifesciences in Q3 2020 and held it in 19 quarters.
- Harrell Investment Partners's Edwards Lifesciences position peaked at $3.16M in Q4 2021.
- 1,261 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.
Based on Harrell Investment Partners's 13F filing for Q2 2025, filed 15 Jul 2025.